Latin America Respiratory devices Market Research Report - Segmented By drugs Type, End User, and Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast | 2024 to 2029

Updated On: January, 2024
ID: 675
Pages: 132

Latin America Respiratory Devices Market Size (2023 to 2028)

The respiratory devices market in Latin America was worth USD 2.24 billion in 2023 and is estimated to grow at a CAGR of 8.74% to reach USD 3.40 billion by 2028.

Respiratory devices aid patients suffering from respiratory problems which cannot attain sufficient oxygen levels to sustain life. Respiratory care devices are used to diagnose, monitor, and treat respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia.

The Latin American respiratory devices market involves the increased use of respiratory such as gas analyzers, pulse oximeters, spirometers, polysomnography, etc. The market is mainly driven by the increased incidences of various acute or chronic respiratory disorders. Although over the past several decades, there has been an increase in the number of patients with respiratory disorders such as chronic obstructive pulmonary disease, tuberculosis, asthma, etc., the high incidence rate is driving the market growth. Chronic respiratory disease affects more than a billion people worldwide, according to the Global Asthma Report, 2018. Asthma is a major contributor and affects children, adults, and the elderly. In addition, around 40 million patients have been affected by asthma. In Latin America, deaths from COPD have increased by 66.9%, and morbidity and mortality rates from COPD and lung cancer are increasing rapidly. Thus, the increasing incidence of respiratory diseases has increased the demand for early diagnosis, which will positively impact the sales of respiratory devices in Latin America.

Respiratory devices such as ventilators, oximeters, etc., have been in high demand due to the COVID-19 outbreak. Ventilators are mainly used in intensive care medicine, home care, emergency medicine, and anesthesia to assist in artificial breathing. In addition, the pandemic has created a need for ventilators, especially in hospitals, for therapeutic assistance.

The increasing rate of newborns and geriatric populations is expected to boost the Latin American respiratory devices market shortly. In addition, increasing the adoption of respirators in emerging economies such as Chile, Peru, and others will create new opportunities for the market. There is also an increased risk of infection in the general population due to the high rate of air pollution in urban cities, which is resulting in the rapid increase in acute respiratory diseases such as bronchitis, allergic rhinitis, and others resulting from air contaminants, this will drive the demand respiratory devices in Latin America. Due to the high demand, many companies in the market are increasingly launching smart respiratory devices, which as smart and automatic to diagnose and monitor several respiratory diseases. In addition, according to the OECD, in 2018, in Chile, there were approximately 34,000 hospital discharges due to asthma, compared with 30,000 hospital discharges in 2017. These numbers are expected to increase during the projected period. Hence, all these factors are expected to boost the Latin American respiratory devices market.

However, factors such as price increases, low healthcare expenditure, refurbished device use, and lack of favorable reimbursement policies are likely to hamper the growth of this market.

This research report on the Latin America Respiratory Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Therapeutic Devices
  • Diagnostic & Monitoring Devices
  • Disposables

By End User: 

  • Hospitals
  • Homecare

By Country: 

  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America

Brazil held the major share of the Latin American respiratory devices market in 2021 due to developed healthcare/medical facilities and the availability of technological advancements. Moreover, the prevalence of smoking and increasing pollution levels are the major reasons for the increase in respiratory disease in the region. Therefore, Brazil is anticipated to hold most of the Latin American respiratory devices market during the projected period, followed by Argentina.

Argentina is expected to experience faster growth at a CAGR of 3.9% during the analysis period, owing to rapid population growth, increased consumer awareness, supportive government policies, rising pollution levels, and an increased medical tourism industry in the region. Other Latin American countries such as Peru, Chile, Ecuador, and Columbia are also projected to have healthy growth owing to the development of efficient and advanced respiratory devices, the growing rate of chronic respiratory diseases such as asthma and COPD, the increased awareness about respiratory diseases, the increase in government initiatives across these regions.


Companies playing a promising role in the Latin America Respiratory Devices Market profiled in the report are Masimo Corporation, ResMed, Inc., Fisher, and Paykel Healthcare Limited, Philips Healthcare, Covidien plc, and CareFusion Corporation.

Please wait. . . . Your request is being processed

Frequently Asked Questions

What is the growth rate of the Latin America respiratory devices market?

The Latin America respiratory devices market is expected to grow at a CAGR of 8.74% from 2022 to 2027.

What are the major factors driving the growth of the Latin America respiratory devices market?

The growing prevalence of respiratory diseases, aging populations, technological advancements in respiratory devices, and increasing healthcare spending in Latin America are majorly driving the respiratory devices market in this region.

What is the competitive landscape of the Latin America respiratory devices market?

The Latin America respiratory devices market is highly competitive, with major players including Philips Respironics, ResMed, Inc., Medtronic, Fisher & Paykel Healthcare, and Drägerwerk AG & Co. KGaA.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample